Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

EM-800, a more potent antiestrogen than raloxifene in preclinical studies

July 14, 1998

New evidence supports the efficacy of PKC inhibition in diabetic neuropathy

July 14, 1998

Idoxifene: another SERM with clinical potential in postmenopausal disorders

July 14, 1998

Prevention of diabetes with nicotinamide -- the DENIS multicenter study

July 14, 1998

Aldose reductase inhibitor from Nippon Zoki effective in rats with diabetic neuropathy

July 13, 1998

Effects of KRP-297 on progression of diabetes in db/db mice

July 13, 1998

Effects of new SGLT inhibitor on insulin and glucose in Zucker diabetic fatty rats

July 13, 1998

M-16049 compared to troglitazone for ability to improve insulin resistance

July 13, 1998

Intensive therapy for type I diabetes may increase cardiovascular disease risk

July 10, 1998

New nonfeminizing estrogens with radical-scavenging activity

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...